Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Patrick Schnable, Alex Vodenlich


Patrick Schnable has been named director of Iowa State University's Plant Sciences Institute.

Schnable is currently a professor in ISU's College of Agriculture and Life Sciences, and received the inaugural chair in genetics in ISU's department of agronomy in 2013.

He also founded and directs the Center for Plant Genomics, a center within the Plant Sciences Institute (PSI) and served as the PSI's associate director 2005 to 2010.

Separately, Schnable is managing partner of Data2Bio, a next-generation sequencing services firm.

KromaTiD has hired Alex Vodenlich as its new CEO.

Vodelinch most recently was president and CEO of Gentel Biosciences, a provider of multiplex immunoassay technologies. Prior to GenTel, Vodenlich served as vice president of sales and marketing for PanVera. Before that, he was a discovery research scientist within Pfizer and Abbott Laboratories.

As incoming CEO, Vodenlich said that the company's goals are to build "revenue traction and to initiate collaborations" to support the launch of KromaTiD's dGH chromosome imaging assays.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.